D-Pharm Ltd.'s DP-b99 Prevents Abnormal Neuronal Plasticity And Pathological Brain Reorganization
6/12/2014 7:19:23 AM
REHOVOT, Israel, June 12, 2014 /PRNewswire via COMTEX/ -- REHOVOT, Israel, June 12, 2014 /PRNewswire/ --
D-Pharm Ltd. (tase:DPRM) announced today, publication in PLOS ONE, of promising results from a study of its drug candidate DP-b99. The findings suggest that DP-b99 may prevent lasting alterations in neuronal function and pathological brain reorganization - a hallmark of numerous central nervous system (CNS) diseases.
Help employers find you! Check out all the jobs and post your resume.
comments powered by